HHC
ANIP icon

Hutchin Hill Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Hutchin Hill Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$844K Buy
+13,100
New +$815K 0.24% 95
2017
Q2 		– Sell
-26,500
Closed -$1.31M – 824
2017
Q1 		$1.31M Buy
+26,500
New +$1.49M 0.04% 421
2015
Q2 		– Sell
-49,500
Closed -$3.1M – 646
2015
Q1 		$3.1M Buy
+49,500
New +$3.01M 0.1% 245
2014
Q2 		– Sell
-9,700
Closed -$304K – 601
2014
Q1 		$304K Buy
+9,700
New +$257K 0.02% 527

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $12B AUM 34.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return